alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### International Trade Commission

          - [Investigation No. 701-TA-431 (Review)] 

# AGENCY:

United States International Trade Commission. 

# ACTION:

Termination of five-year review. 

# SUMMARY:

The subject five-year review was initiated in July 2008 to determine whether revocation of the countervailing duty order on DRAMs and DRAM modules from Korea would be likely to lead to continuation or recurrence of material injury. On October 3, 2008, the Department of Commerce published notice that it was revoking the order effective August 11, 2008, “{b}ecause the domestic interested party did not file a substantive response by the applicable deadline and has withdrawn its notice of intent to participate in this sunset review * * *” (73 FR 57594). Accordingly, pursuant to section 751(c) of the Tariff Act of 1930 (19 U.S.C. 1675(c)), the subject review is terminated. 

# DATES:

*Effective Date:*                         August 11, 2008.                     

# FOR FURTHER INFORMATION CONTACT:

                        Mary Messer (202-205-3193), Office of Investigations, U.S. International Trade Commission, 500 E Street, SW., Washington, DC 20436. Hearing-impaired individuals are advised that information on this matter can be obtained by contacting the Commission's TDD terminal on 202-205-1810. Persons with mobility impairments who will need special assistance in gaining access to the Commission should contact the Office of the Secretary at 202-205-2000. General information concerning the Commission may also be obtained by accessing its Internet server (                        *http://www.usitc.gov*).                     

Authority:This review is being terminated under authority of title VII of the Tariff Act of 1930; this notice is published pursuant to section 207.69 of the Commission's rules (19 CFR 207.69). 

By order of the Commission. 

Issued: October 10, 2008. 

Marilyn R. Abbott, 

Secretary to the Commission. 

[FR Doc. E8-24601 Filed 10-16-08; 8:45 am] 

BILLING CODE 7020-02-P
United States Court of Appeals

For the Eighth Circuit

___________________________

No. 20-1893

___________________________

Corey Spector

lllllllllllllllllllllPlaintiff - Appellant

v.

Accredited Home Loans, Inc.; Select Portfolio Services; Millsap & Singer, P.C., as

Trustee; U.S. Bank, N.A., as Trustee, as successor-in-interest to Bank of America,

N.A., as Trustee as successor by merger to LaSalle Bank, N.A., as Indenture

Trustee for the holders of the Accredited Mortgage Loan Trust 2005-3 Asset

Backed Notes

lllllllllllllllllllllDefendants - Appellees

 ____________

Appeal from United States District Court 

for the Eastern District of Missouri - St. Louis

 ____________

 Submitted: February 26, 2021 

Filed: March 2, 2021

[Unpublished]

____________

Before LOKEN, COLLOTON, and KOBES, Circuit Judges. 

____________

PER CURIAM.
Corey Spector appeals the district court’s1

 dismissal of his action. He argues

on appeal that the district court erred in dismissing his wrongful foreclosure claim,

and erred by not granting him leave to amend his complaint. Upon careful de novo

review, see Ballinger v. Culotta, 322 F.3d 546, 548 (8th Cir. 2003) (standard of

review), we affirm. We find that Spector’s wrongful foreclosure claim was barred by

res judicata, as he previously litigated the same claim in state court, and the same

parties or their privies were involved in the state court proceedings. See Brown v.

Kan. City Live, LLC, 931 F.3d 712, 714 (8th Cir. 2019) (elements of res judicata

under Missouri law); Kesterson v. State Farm Fire & Cas. Co., 242 S.W.3d 712, 716

(Mo. 2008) (en banc) (where evidentiary details needed to prove claims were

different, but crux of inquiry was same, res judicata applied); Meadowfresh Sols.

USA, LLC v. Maple Grove Farms, LLC, 606 S.W.3d 193, 205 (Mo. Ct. App. 2020)

(assignee was in privity with assignor); Topchian v. JPMorgan Chase Bank, N.A.,

539 S.W.3d 879, 901 (Mo. Ct. App. 2017) (attorney appointed by bank for

foreclosure was in privity with bank). We also find that the district court did not err

in failing to grant Spector leave to amend his complaint. See Clayton v. White Hall

Sch. Dist., 778 F.2d 457, 460 (8th Cir. 1985) (no abuse of discretion in failing to

grant leave to amend where appellant merely concluded response to motion to dismiss

with request for leave to amend, and did not offer proposed complaint or even

substance of proposed amendment to court).

The judgment is affirmed. See 8th Cir. R. 47B.

______________________________

1The Honorable Stephen R. Clark, United States District Judge for the Eastern

District of Missouri.

-2-
EXHIBIT 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In  connection  with the Annual  Report of  Central  Jersey  Bancorp  (the
"Company") on Form 10-K for the year ended December 31, 2006 (the "Report"),  I,
Anthony  Giordano,  III,  Executive Vice  President,  Chief  Financial  Officer,
Treasurer and Assistant Secretary of the Company, do hereby certify, pursuant to
18 U.S.C.  ss.1350,  as adopted pursuant to ss.906 of the  Sarbanes-Oxley Act of
2002, that to my knowledge:

(1)   the Report fully  complies with the  requirements  of ss.13(a) or 15(d) of
      the Securities Exchange Act of 1934, 15 U.S.C. ss.78m or 78o(d), and,

(2)   the information  contained in the Report fairly presents,  in all material
      respects,  the  financial  condition  and  results  of  operations  of the
      Company.


Dated: March 14, 2007              /s/ Anthony Giordano, III
                                   -----------------------------------------
                                   Anthony Giordano, III
                                   Executive Vice President, Chief Financial
                                   Officer, Treasurer and Assistant Secretary
#### Thomas Marion McGAHA, Appellant, v. The STATE of Texas, Appellee.

No. 46559.

Court of Criminal Appeals of Texas.

March 7, 1973.

Jim Skelton, Houston, for appellant.

Carol Vance, Dist. Atty., James C. Brough and Ned Morris, Asst. Dist. Attys., Houston, Jim D. Vollers, State’s Atty., and Robert A. Huttash, Asst. State’s Atty., Austin, for the State.

OPINION

DAVIS, Commissioner.

Appeal is taken from a conviction of burglary with intent to commit theft. After the enhancement portion of the indictment had been dismissed on motion of the State, appellant entered a plea of guilty before the court and punishment was assessed at ten years.

Appellant’s court-appointed attorney has filed a brief in which he concludes the present appeal is frivolous. Nevertheless, aware of his responsibility to do so, counsel has set out alleged grounds of error that might be considered for reversal in the event this court does not agree with him that the appeal is frivolous. Further, the record reflects that appellant has been served with a copy of appellant’s brief. No pro se brief has been filed. The procedure is in accordance with Anders v. California, 386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 and Gainous v. State, Tex.Cr.App., 436 S.W.2d 137.

The record has been reviewed and the alleged grounds of error have been considered, and this court concludes that the appeal is without merit and wholly frivolous.

No motion for rehearing will be filed by the clerk except by leave of this Court upon a showing of good cause.

The judgment is affirmed.

Opinion approved by the Court.
<TABLE> <S> <C>

<PAGE>
<ARTICLE>  5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED
FROM THE CONSOLIDATED FINANCIAL STATEMENTS FOUND ON PAGES 3 AND 4
OF THE COMPANY'S FORM 10-QSB FOR THE SIX-MONTHS ENDED
SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

<S>                                   <C>
<PERIOD-TYPE>                         6-MOS
<FISCAL-YEAR-END>                     MAR-31-2001
<PERIOD-START>                        APR-01-2000
<PERIOD-END>                          SEP-30-2000
<CASH>                                  485,362
<SECURITIES>                                  0
<RECEIVABLES>                           345,567
<ALLOWANCES>                              3,000
<INVENTORY>                             439,373
<CURRENT-ASSETS>                      1,310,387
<PP&E>                                6,495,072
<DEPRECIATION>                        4,302,828
<TOTAL-ASSETS>                        3,860,341
<CURRENT-LIABILITIES>                   391,694
<BONDS>                               1,999,457
<PREFERRED-MANDATORY>                         0
<PREFERRED>                                   0
<COMMON>                                  5,611
<OTHER-SE>                            1,463,579
<TOTAL-LIABILITY-AND-EQUITY>          3,860,341
<SALES>                                 978,017
<TOTAL-REVENUES>                      1,364,652
<CGS>                                   569,077
<TOTAL-COSTS>                         1,518,766
<OTHER-EXPENSES>                        (38,846)
<LOSS-PROVISION>                              0
<INTEREST-EXPENSE>                        1,927
<INCOME-PRETAX>                        (115,268)
<INCOME-TAX>                                  0
<INCOME-CONTINUING>                    (115,268)
<DISCONTINUED>                                0
<EXTRAORDINARY>                               0
<CHANGES>                                     0
<NET-INCOME>                           (115,268)
<EPS-BASIC>                               (.021)
<EPS-DILUTED>                             (.021)


</TABLE>
<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0000769131
<NAME>                        RANCON REALTY FUND V
<MULTIPLIER>                                   1000
<CURRENCY>                                     U.S. Dollars

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-2000
<PERIOD-START>                                 JAN-01-2000
<PERIOD-END>                                   MAR-31-2000
<EXCHANGE-RATE>                                1.000
<CASH>                                         5,524
<SECURITIES>                                   0
<RECEIVABLES>                                  7,429
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               5,635
<PP&E>                                         49,654
<DEPRECIATION>                                 18,599
<TOTAL-ASSETS>                                 45,665
<CURRENT-LIABILITIES>                          417
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     27,836
<TOTAL-LIABILITY-AND-EQUITY>                   45,665
<SALES>                                        0
<TOTAL-REVENUES>                               1,853
<CGS>                                          0
<TOTAL-COSTS>                                  813
<OTHER-EXPENSES>                               769
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             306
<INCOME-PRETAX>                                (35)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (35)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (35)
<EPS-BASIC>                                    (0.36)
<EPS-DILUTED>                                  (0.36)



</TABLE>
2014-05-15 Exhibit - Master Lease

















































	
			
	Lessor:
	 
	Lessee:

	FIRST NATIONAL CAPITAL, LLC
	 
	MILLER ENERGY RESOURCES, INC., AND

	 
	 
	ALL AFFILIATES AND SUBSIDIARIES

	 
	 
	 

	By: /s/ Keith Duggan
	 
	By: /s/ Scott M. Boruff

	Name: Keith Duggan
	 
	Name: Scott M. Boruff

	Title: Manager
	 
	Title: Chief Executive Officer
Exhibit 32.1

CERTIFICATION FURNISHED PURSUANT TO  18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Techwell, Inc. (the "Company") for the annual period ended December 31, 2007
as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Fumihiro Kozato, Chief Executive Officer of the Company hereby certifies, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of his knowledge, that:



| |  |  | /s/FUMIHIRO KOZATOFumihiro Kozato President and Chief Executive OfficerMarch 12, 2008
| |  |  | -------------------------------------------------------------------------------------

---



QuickLinks
Exhibit 12.1  I, Kevin Hanson, Chief Executive Officer, certify that:  1. I have reviewed this Annual Report on Form 20-F of Brockton Capital Corp.;  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Annual Report;  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;  4. The companys other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d -15(f)) for the company and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Evaluated the effectiveness of the companys disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (c) Evaluated the effectiveness of the company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the companys internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the companys internal control over financial reporting; and  5. The companys other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the companys auditors and the audit committee of the companys board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the companys ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the companys internal control over financial reporting.   Date: December 15, 2006   Kevin Hanson___________ Chief Executive Officer
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                            1550
<SECURITIES>                                         0
<RECEIVABLES>                                        8
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                  1558
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                    1558
<CURRENT-LIABILITIES>                               80
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                        1478
<TOTAL-LIABILITY-AND-EQUITY>                      1558
<SALES>                                              0
<TOTAL-REVENUES>                                    46
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                    76
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                   (30)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                               (30)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (30)
<EPS-BASIC>                                   (0.51)
<EPS-DILUTED>                                   (0.51)


</TABLE>
[Federal Register Volume 75, Number 166 (Friday, August 27, 2010)]
[Notices]
[Page 52768]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-21295]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0002]


Withdrawal of Approval of New Animal Drug Applications; 
Dichlorophene and Toluene Capsules

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is withdrawing 
approval of two new animal drug applications (NADAs) for use of 
dichlorophene and toluene deworming capsules for cats and dogs. In a 
final rule published elsewhere in this issue of the Federal Register, 
FDA is amending the regulations to remove portions reflecting approval 
of these NADAs.

DATES:  Withdrawal of approval is effective September 7, 2010.

FOR FURTHER INFORMATION CONTACT:  John Bartkowiak, Center for 
Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 
Standish Pl., Rockville, MD 20855, 240-276-9079; email: 
<a href="/cdn-cgi/l/email-protection#fa90959294d4989b888e91958d939b91ba9c9e9bd4929289d49d958c"><span class="__cf_email__" data-cfemail="95fffafdfbbbf7f4e7e1fefae2fcf4fed5f3f1f4bbfdfde6bbf2fae3">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: Pegasus Laboratories, Inc., 8809 Ely Rd., 
Pensacola, FL 32514 has requested that FDA withdraw approval of NADA 
101-497 for TINY TIGER (dichlorophene/toluene) Worming Capsules, NADA 
101-498 for LK (dichlorophene/toluene) Worming Capsules because they 
are no longer manufactured or marketed.
    Therefore, under authority delegated to the Commissioner of Food 
and Drugs and redelegated to the Center for Veterinary Medicine, and in 
accordance with Sec.  514.116 Notice of withdrawal of approval of 
application (21 CFR 514.116), notice is given that approval of NADAs 
101-497 and 101-498, and all supplements and amendments thereto, is 
hereby withdrawn, effective September 7, 2010.
    In a final rule published elsewhere in this issue of the Federal 
Register, FDA is amending the animal drug regulations to reflect the 
withdrawal of approval of these NADAs.

    Dated: August 23, 2010.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2010-21295 Filed 8-26-10; 8:45 am]
BILLING CODE 4160-01-S


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>